Richard Scher, DO
Board Certifications: Internal Medicine, Hematology and Medical Oncology
Languages: English
Locations: Little Silver, NJ
Call Little Silver, NJ: (732) 530-8666
Richard Scher, DO, is a Hematology and Medical Oncology specialist working in Little Silver, New Jersey. He has over 38 years of experience serving his community with the highest level of care. He works with all types of solid and liquid malignancies, including various cancers and hematology conditions. Patients trust him to use the most advanced and appropriate treatments to help them secure the best possible care outcomes.
Clinical Interests and expertise
Dr. Scher has served the New Jersey region for over 38 years. He has expertise with diverse types of solid tumor and expertise in malignant and benign blood disorders. His treatment approach prioritizes recent innovations, particularly in chemotherapy and targeted therapy, that deliver excellent outcomes with minimal side effects. Not only do these treatments improve patient prognosis; they also help patients stay comfortable through the treatment process.
Professional Background and Academic Achievements
While completing his residency, Dr. Scher was appointed Chief Resident at Newark Beth Israel Medical Center. While in this position, he fulfilled an administrative and leadership role in addition to providing patient care. He also taught younger residents and acted as a liaison between program participants and physicians.
Dr. Scher is a member of American Society of Clinical Oncologists (ASCO), the largest association of oncologists and the world’s leading professional organization for cancer care and research. His membership empowers him to share knowledge and collaborate with other top oncologists, giving him access to the most recent advances in cancer care.
Education & Training
Medical school: University of Medicine and Dentistry of New Jersey: School of Osteopathic Medicine, 1983
Residency: New Jersey Medical School, Internal Medicine, 1987
Fellowship: Temple University/Fox Chase Cancer Center, Hematology and Oncology, 1990
Board certifications: Internal Medicine, Hematology, and Medical Oncology
Call Little Silver, NJ: (732) 530-8666
About Richard Scher, DO
Dr. Scher has been practicing in the fields of hematology and oncology for over three decades. During this time, he has found his work deeply rewarding. “It is an opportunity to make a profound impact on patients’ lives,” he states. He enjoys working to improve patients’ lives through effective care, helping them overcome or manage disease.
“My goal,” says Dr. Scher, “is to partner with a patient and family.” His approach to care is patient-centered. He works with each individual to help them understand their diagnosis and plan the most appropriate treatment. While doing so, he makes efforts to minimize fear and foster hope.
Hope, to him, is important to remember while undergoing cancer treatment. “With innovative therapies evolving constantly,” he says, “we are now providing treatments… that did not even exist a year ago.” These treatments are highly effective and often come with minimal side effects. Some of them introduce cures for diagnoses that were previously uncurable. Even when a cure is not possible, new advances create better prognoses and improved quality of life.
Finally, he states, “This is a group effort.” Cancer care is not an individual journey; instead, it is a collaboration between patients, physicians, and the compassionate staff at RCCA, who are always available to help with cancer care. You are not alone.
Locations
Dr. Scher treats patients at Regional Cancer Care Associates (RCCA) in Little Silver, NJ.
Ste. 101
Little Silver NJ 07739
Hospital Affiliations
He is also affiliated with Riverview Medical Center, which is part of the Hackensack Meridian Health network.
We are here for you
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.